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Borna disease virus (BDV), a nonsegmented, negative-strand RNA virus, infects a wide 24 
variety of mammalian species and readily establishes a long-lasting, persistent infection in 25 
brain cells. Therefore, this virus could be a promising candidate as a novel RNA virus vector 26 
enabling stable gene expression in the central nervous system (CNS). Previous studies 27 
demonstrated that the 5’ untranslated region of the genome is the only site for insertion and 28 
expression unit of a foreign gene. In this study, we established a novel BDV vector, in which 29 
an additional transcription cassette has been inserted into an intercistronic noncoding region 30 
between the viral phosphoprotein (P) and matrix (M) genes. The recombinant BDV (rBDV) 31 
carrying green fluorescent protein (GFP) between the P and M genes, rBDV P/M-GFP, 32 
expressed GFP efficiently in cultured cells and rodent brains for a long-period of time without 33 
attenuation. Furthermore, we generated a non-propagating rBDV, ΔGLLP/M, which lacks the 34 
envelope glycoprotein (G) and a splicing intron within the polymerase gene (L), by the 35 
trans-complementation system with either transient or stable expression of the G. Interestingly, 36 
rBDV ΔGLLP/M established a persistent infection in cultured cells with stable expression of 37 
GFP in the absence of the expression of G. Using persistently infected rBDV 38 
ΔGLLP/M-infected cells, we determined the amino acid region in the cytoplasmic tail (CT) of 39 
BDV G important for the release of infectious rBDV particles and also demonstrated that the 40 
CT region may be critical for the generation of pseudotyped rBDV having vesicular stomatitis 41 
virus G protein. Our results revealed that the newly established BDV vector constitutes an 42 
alternative tool, not only for stable expression of foreign genes in the CNS but also for 43 
understanding the mechanism of the release of enveloped virions.  44 
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Introduction  45 
Borna disease virus (BDV) belongs to the Bornaviridae family within the non-segmented, 46 
negative-strand RNA viruses and is characterized by highly neurotropic and noncytopathic 47 
infection (18, 31). Previous studies revealed that BDV infects a wide variety of mammalian 48 
species, suggesting that its host range probably includes all warm-blooded animals. The most 49 
striking feature of BDV is that it readily establishes a long-lasting persistent infection in the 50 
cell nucleus (9, 31). BDV establishes a stable infection without causing apparent cell damage, 51 
even in brain cells (8), making this the only animal RNA virus capable of intranuclear 52 
parasitism. These features of BDV suggest that this virus could be a promising candidate for 53 
efficient and stable gene delivery system to the central nervous system (CNS). 54 
Recent developments of the reverse genetics system of BDV revealed that the virus has 55 
the capacity to express foreign genes from the 5’ end of the genome (26). Recombinant BDV 56 
(rBDV) with green fluorescence protein (GFP) near the 5’ end of the genome (rBDV 5’GFP) 57 
successfully infected, and was propagated in, cultured cells. This study suggested that the 5’ 58 
end of the BDV genome might be the only site for insertion of the GFP expression cassette, 59 
because rBDV could not be rescued after introduction of the cassette into other regions of the 60 
genome (26). On the other hand, a recent study using the rBDV 5’GFP revealed that the 61 
termination signal upstream of the GFP gene is modified by insertion of additional A residues, 62 
resulting in downregulation of GFP expression within several weeks of infection of rat brains 63 
(2). This observation suggested that although the 5’ end of the BDV genome is capable of the 64 
expression of a foreign gene, an additional transcriptional cassette in this region may affect 65 
the replication of BDV adversely, probably because of destruction of specific genome-end 66 
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structures, such as the inverted terminal repeat (ITR) and panhandle structure, both of which 67 
could be important for the transcription/replication processes of the viral polymerase (24, 25, 68 
27). Furthermore, because there is a clear polarity of initiation of transcription from the 3’ end 69 
to the 5’ end of the genome in mononegaviruses (17, 23, 29), a transcription unit at the 5’ end 70 
of the genome may be unsuitable for efficient expression of foreign genes. Considering the 71 
complexities of genome construction and the transcription mechanism of BDV, it may be 72 
conceivable that BDV has a lower capacity than other mononegaviruses for the insertion of an 73 
additional expression unit in the genome. 74 
As well as the site of insertion of a foreign gene cassette in the genome, the flexibility 75 
of the virus genome to retain the capacity to replicate efficiently, as well as host cell tropism, 76 
also could be important in establishing a more effective and useful virus vector system. In 77 
many virus vectors, propagation-defective and pseudotyped viruses have been developed by 78 
modifying viral genomes and deletion or mutation of viral genes (4, 5, 13, 35). In BDV, some 79 
point mutations, including in the phosphoprotein (P), X and RNA polymerase (L) genes, have 80 
been shown to modify the efficiency of virus replication in cultured cells and animal brains (1, 81 
21). For example, two amino acid substitutions, L1116R and N1398D, in the L gene are 82 
known to enhance significantly the polymerase activity, as well as the replication kinetics, of 83 
rBDV (1). However, there have been only few studies on the modification of the viral genome 84 
to develop the efficient and safe BDV vector system. 85 
In this study, we established a novel BDV vector, BDV P/M, which harbors an extra 86 
transcription unit in the short intercistronic noncoding region of the genome between the P 87 
and matrix (M) genes, P/M. BDV P/M was shown to stably express several reporter genes, 88 
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including GFP, DsRed and luciferase, in cultured cells without attenuation of their expression. 89 
Furthermore, we developed a non-propagating rBDV, ΔGLLP/M, which lacks an envelope 90 
glycoprotein (G) gene and a splicing intron within the L gene, by the trans-complementation 91 
of the G. Interestingly, rBDV ΔGLLP/M-GFP was able to establish persistent infection in a 92 
single cell without the expression of G. We also show that the cytoplasmic tail (CT) of BDV G 93 
may be essential for the release of infectious particles and the generation of pseudotyped 94 
BDV virions having vesicular stomatitis virus (VSV) G protein, by using the rBDV 95 
ΔGLLP/M virus system. Our results show that the BDV P/M vectors may constitute a new 96 
system, not only for efficient and safe gene delivery in vivo, but also for understanding the 97 
mechanism of envelope assembly and virion formation of BDV, which also could be 98 
important for improving the utility of BDV as a virus vector. 99 
 100 
Materials and Methods 101 
Cells.   Vero cells and Vero cells stably expressing BDV G (Vero-BG) were cultured in 102 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 2% fetal bovine serum 103 
(FBS). The OL cell line, derived from a human oligodendroglioma, was cultured in 104 
DMEM-high glucose (4.5%) supplemented with 5% FBS. HEK 293T cells were cultured in 105 
DMEM supplemented with 10% FBS.  106 
 107 
Plasmid constructions.   The RNA polymerase II (Pol II)-driven BDV minigenome 108 
plasmid, pCAG-HRSV3, has been described previously (34). To generate a plasmid 109 
expressing the BDV full-length antigenome RNA, pFct-BDV, a cloned full-length cDNA of 110 
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BDV strain He/80 was inserted into the Xho I and Not I sites of pCAG-HRSV3. A plasmid 111 
containing an extra transcription cassette, pFct-BDV P/M, was generated by insertion of 112 
transcription initiation (S3) and termination (T2) signal sequences in the P/M region with 113 
BstB I and Pac I sites (Fig. 1A). The plasmid harboring the expression cassette in the 5’ end 114 
of the genome, pFct-BDV 5’, also was constructed using the BstB I and Pac I restriction 115 
enzymes. The LRD mutation (1) was introduced into the pFct-BDV P/M plasmid by 116 
PCR-based mutagenesis. To generate foreign gene expression vectors, reporter genes, 117 
including GFP, DsRed, luciferase and LacZ were amplified from peGFP-N1 (Clontech), 118 
pDsRed-Monomer-C1 (Clontech), pGL3-Promoter Vector (Promega), and pcDNA 5/TO/lacZ 119 
(Invitrogen) and inserted into pFct-BDV P/M or pFct-BDV ΔGLLP/M vector with BstB I and 120 
Pac I sites. 121 
The pFct-BDV ΔGP/M-GFP, in which two ATG codons (nt 2236 and 2248) in the G 122 
ORF were changed to ACG, was constructed from pFct-BDV P/M GFP by PCR mutagenesis 123 
(Fig. 3A). The intron II-deleted, L ORF-linearized BDV vector, pFct-BDV ΔGLLP/M GFP, 124 
was developed by deleting the intron II sequence (nt 2410 to 3703) from pFct-BDV ΔGP/M 125 
GFP using a PCR amplification method (Fig. 3A). 126 
The expression vector, pBDV-G, was generated by subcloning the G ORF of strain 127 
He/80 into the Kpn I and Sma I sites of plasmid pCXN2. For efficient expression of BDV G in 128 
transfected cells, silent mutations were introduced at the splicing donor (SD) and acceptor 129 
(SA) sequences in the G gene. The cDNA of VSV G was amplified from pVPack-VSV-G 130 
(Stratagene) and subcloned into the EcoR I and EcoR V sites of pCXN2 vector to yield 131 
pVSV-G. The rabies virus (RaV) G expression plasmid, pRaV-G, was constructed by 132 
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subcloning of the Nishigahara strain G, which was kindly gifted by Naoto Ito (Gifu University, 133 
Japan), into the Kpn I and EcoR V sites of pCXN2 vector. Expression plasmids of chimeric G 134 
proteins of VSV and RaV, in which the CT regions were exchanged with that of BDV G, were 135 
constructed by PCR mutagenesis. Detailed information about the primers and PCR procedures 136 
used to generate these plasmids is available from the authors. Nucleotide sequences of the 137 
recombinant plasmids were confirmed by DNA sequencing. 138 
 139 
Virus rescue.   293T cells were seeded in 35 mm dishes and transfected with 2 µg of BDV 140 
vector plasmid, 0.25 µg of pCA-N (34), 0.025 µg of pCXN2-P (34) and 0.25 µg of pCA-L 141 
(34) using LipofectamineTM2000 (Invitrogen). To rescue rBDV ΔGP/M GFP and ΔGLLP/M 142 
GFP, 0.1 µg of pBDV-G was transfected together with the helper plasmids expressing BDV N, 143 
P and L into 293T cells. Three days posttransfection, the cells were detached using trypsin and 144 
seeded onto 10 cm dishes. One day after the first passage, approximately 1 × 105 Vero or 145 
Vero-BG cells were cocultured with the transfected 293T cells. The cultures were split every 3 146 
days and the rescue efficacy of recombinant viruses was evaluated by fluorescence 147 
microscopy using an anti-BDV N monoclonal antibody (mAb) or by monitoring the 148 
expression of GFP. The non-propagating rBDVs were rescued by transient transfection with 149 
expression plasmids encoding BDV, VSV and RaV G and chimeric G protein between these 150 
viruses. Vero cells stably infected with rBDV ΔGLLP/M-GFP in 35 mm dishes were 151 
transfected with 3 µg of the G expression construct using LipofectamineTM2000 (Invitrogen) 152 
and the virus particles were collected from the culture supernatant or from sonicated cells at 153 




Virus infection.   Vero or Vero-BG cells were infected with the amounts of rBDV stock 156 
indicated at 37ºC. After absorption for 1 h, the cells were washed with PBS (-) and passaged 157 
with the appropriate interval of a few days. Virus propagation was detected by indirect 158 
immunofluorescence or GFP assay.  159 
C57BL/6J mice and Lewis rats (Oriental Yeast Co. Ltd., Shiga, Japan) were inoculated 160 
intracranially with 1 × 103 focus forming units (FFU) of rBDV stock per animal within 24 h 161 
of birth. The infected animals were sacrificed at the appropriate month after inoculation and 162 
the brains were collected for analysis. To assess GFP expression in the brain, the whole or 163 
cross sections of the brains were rinsed with PBS (-) and examined under a Leica WILD M10 164 
fluorescence stereomicroscope (Leica Microsystems, Wetzlar, Germany). Brain samples were 165 
then fixed in 4% paraformaldehyde, cryopreserved in 25% sucrose, and frozen in Tissue-Tek 166 
O.C.T. compound. Cryostat sections (4 µm) were examined under a fluorescence microscope. 167 
Sections also were examined by immunohistochemical analysis after staining with anti-BDV 168 
N mAb. All animal experimentation conformed to the guide for the care and use of laboratory 169 
animals of the Research Institute for Microbial Diseases, Osaka University.   170 
 171 
Histological analysis.   Frozen sections were incubated with trypsin solution (0.1% trypsin, 172 
0.1% CaCl2, and 0.05 M Tris-HCl, pH 7.5) for 5 min at 37ºC. The sections were then 173 
permeabilized by PBS (-) with 0.05% Triton-X and blocked with 10% normal goat serum in 174 
PBS (-) for 30 min at room temperature. The sections were incubated with primary antibody 175 
with 5% normal goat serum in PBS (-) overnight at 4ºC and then with the secondary 176 
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antibodies with PBS (-) for 1 hour at 37ºC. The cells were counterstained with 177 
4’,6’-diamidino-2-phenylindole (DAPI). 178 
 179 
Indirect immunofluorescence assay (IFA).   Cells were fixed with 4% paraformaldehyde 180 
and permeabilized by PBS (-) with 0.4% Triton-X. After permeabilization, the cells were 181 
incubated with the primary antibody, anti-BDV N mAb, for 1 h at 37ºC. Subsequently, the 182 
cells were washed three times with PBS (-) and incubated with secondary antibody, goat 183 
anti-mouse IgG antibody conjugated with Cy3 (Jackson Immuno Research) or goat anti-rabbit 184 
IgG antibody conjugated with Alexa Fluor 488 (Invitrogen) for 1 h at 37ºC. The cells were 185 
counterstained with DAPI. After further washing with PBS (-), the cells were examined with 186 
an inverted microscope Ti-E with a confocal laser scanning system C1 (Nikon). 187 
 188 
Luciferase and LacZ reporter assays.   Vero cells were infected with rBDV 189 
P/M-luciferase in 16 mm culture dishes. At 24, 48 and 72 h postinfection, cells were lysed and 190 
subjected to luciferase assay with Luciferase Cell Culture Lysis Reagent (Promega), 191 
according to the manufacturer’s recommendations. The activity of β-Galactosidase from the 192 
rBDV ΔGLLP/M-LacZ infected Vero-BG cells was analyzed by β-Galactosidase Staining Kit 193 
(PanVera), according to the manufacture’s recommendations.  194 
 195 
Western blot analysis.   Vero cells infected with rBDV were lysed and the proteins 196 
separated with 12% SDS-PAGE, followed by transfer to Immobilon-P Transfer Membrane 197 
(Millipore). Membranes were then blocked with 5% skimmed milk in PBS (-) and incubated 198 
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with the primary antibodies (anti-BDV N and P mAb and anti-BDV M and G polyclonal 199 
antibodies [pAb]. After three washes with 0.05% Tween-20 in PBS (-), horseradish 200 
peroxidase-conjugated secondary antibodies (Jackson Immuno Research) were applied for 1 h 201 
at 37ºC. The membrane was washed three times and bound antibodies were detected using the 202 
ECL Western Blotting System (Amersham Pharmacia Biotech).  203 
 204 
Northern blot analysis.   Total RNA was extracted from cells infected with rBDV with 205 
TRIzol reagent (Invitrogen). Aliquots of 1.0 μg of total RNA were electrophoresed through a 206 
1.0% agarose gel containing 2.2% formaldehyde and transferred onto Nylon Membranes 207 
(Roche) with 20 × SSC (1 × SSC = 150 mM NaCl plus 15 mM sodium citrate, pH 7.0). After 208 
UV cross-linking, the membrane was prehybridized in hybridization solution for 30 min at 209 
65ºC. This step was followed by hybridization overnight with a digoxigenin (DIG)-labeled 210 
RNA probe. The hybridized probe was detected with an alkaline phosphatase-conjugated 211 
anti-DIG Fab fragment (Roche) 212 
 213 
Results 214 
Efficient expression of foreign genes from an intercistronic region between the P and M 215 
genes of BDV.   A previous study by Schneider et al. (2007) showed that 216 
replication-competent rBDV was not able to be rescued when an extra transcription unit was 217 
inserted into the P/M region of the BDV genome (26). To examine further the availability of 218 
the P/M region for expression of a foreign gene, we inserted a GFP cassette into the site as 219 
indicated in Fig. 1A. The nucleotide sequences of the cassette could be slightly different from 220 
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those reported previously, at least in terms of the restriction enzyme sites for cloning of the 221 
cassette, whilst both cassettes use the same T2 and S3 sequences for additional transcription 222 
termination and initiation signals, respectively (Fig. 1A). We transfected the resultant plasmid, 223 
pFct-BDV P/M-GFP, which is driven by the Pol II promoter, into 293T cells along with helper 224 
plasmids (see Materials and Methods). A few weeks after cocultivation with Vero cells, rBDV 225 
harboring the GFP gene in the P/M region, termed rBDV P/M-GFP, was rescued successfully 226 
(Fig. 1B). Consistent with previous studies (26), the L1116R and N1398D mutations in the L 227 
gene (LRD) enhanced the efficiency of rescue of the rBDV P/M-GFP virus (data not shown) 228 
and, therefore, we used the LRD mutant plasmid in the backbone of BDV P/M vectors for 229 
further experiments.  230 
At first, we infected Vero cells with cell-free rBDVs at a multiplicity of infection (MOI) 231 
of 0.01 and the growth kinetics of rBDV P/M-GFP were compared to wild-type (wt) 232 
recombinant virus and rBDV 5’GFP. As shown in Fig. 1C, the growth kinetics of both 233 
GFP-expressing viruses seemed to be slightly retarded compared to wt rBDV but they were 234 
propagated efficiently and reached over 90% infection by 3 weeks postinfection. We also 235 
performed IFA to investigate the expression of GFP in Vero cells. As shown in Fig. 1D, rBDV 236 
P/M-GFP induced an apparently stronger GFP signal than rBDV 5’GFP, while the expression 237 
of N is comparable among the various recombinant viruses. The western and northern blot 238 
analyses confirmed higher expression of GFP from the P/M region than the 5’ end of the 239 
genome (Figs. 1E and F).  240 
In addition to the GFP gene (720 bp), we could rescue rBDV P/M viruses harboring 241 
DsRed (678 bp) and luciferase (1653 bp) in the P/M region and verified the stable expressions 242 
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of these genes in infected cells. Both the rescue efficiency and growth kinetics of rBDV 243 
P/M-DsRed and -Luc were quite comparable to that of P/M-GFP virus (data not shown). 244 
Using rBDV P/M-Luc, we could monitor the transcription of BDV in infected cells at a very 245 
early stage of infection. The luciferase activity was clearly detected in Vero cells as early as 246 
72 h postinfection (Fig. 1G), at which time BDV replication had not been demonstrated by 247 
other methods. Furthermore, efficient expression of DsRed was also demonstrated in Vero 248 
cells infected with the rBDV (Fig. 1H). The signal intensity of DsRed appeared to be overall 249 
equal to that of GFP, suggesting that the P/M region has the capacity to harbor various genes 250 
without attenuating viral replication.  251 
 252 
Stable expression of GFP in rBDV P/M-GFP-infected rodent brains.   To investigate 253 
whether rBDV P/M can efficiently and stably express a foreign gene in animal brains, we 254 
inoculated 1.0 x 103 FFU of rBDV P/M-GFP and 5’GFP viruses intracranially into neonatal 255 
Lewis rats and C57BL/6J mice and GFP expression was monitored by fluorescence 256 
stereomicroscopic and immunohistochemical analyses. As shown in Fig. 2A, a GFP signal 257 
was detected in the injected hemisphere of the rBDV P/M-GFP-infected rat brain and was 258 
much brighter than that of the 5’GFP at 2 weeks postinoculation. The expression of GFP was 259 
clearly visible in the neurons of the cerebrum cortex and cerebellum at 2 months after 260 
inoculation (Fig. 2B). Although the N-positive neurons were detected equally in the brain 261 
regions after infection by rBDV P/M-GFP and 5’GFP viruses, GFP fluorescence seemed to be 262 
much greater in the neurons infected with rBDV P/M-GFP than with 5’GFP virus (Fig. 2B). 263 
Furthermore, the stable expression of GFP from the P/M-GFP virus was demonstrated in 264 
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mouse brains (Fig. 2C). The neurons in the hippocampus region of infected mice showed a 265 
strong GFP fluorescence at 2-months postinoculation (Fig. 2C). Notably, the GFP signal in the 266 
brains of rBDV P/M-GFP-infected mice was observed and stable over an observation period 267 
of at least 8 months (Fig. 2D). These results indicated that rBDV P/M can establish a 268 
persistent infection, leading to the lasting expression of foreign gene in the brains. 269 
Previous work using virus vectors derived from mononegaviruses revealed that 270 
insertion of an additional transcriptional unit into viral gene junctions causes mutations of the 271 
transcriptional initiation or termination sites that control the transcription of the inserted or 272 
neighboring genes (2, 33). Therefore, we next determined using RT-PCR whether the 273 
sequences of the newly introduced transcriptional cassette are stable during the replication of 274 
the P/M-GFP virus. No sequence alterations or deletions were found to have been introduced 275 
into the rBDV P/M-GFP genome at least 8 months after infection of mouse brains (data not 276 
shown), suggesting the additional transcriptional unit and its surrounding sequences are fairly 277 
stable during the multiplication of the P/M-GFP virus in the brains.  278 
 279 
Generation of propagation-defective rBDV P/M viruses lacking the translation initiation 280 
codons for the G gene and an intron region within the L gene.   To improve the BDV 281 
P/M vector system, we next tried to generate propagation-defective rBDV P/M. First, we 282 
changed two ATG codons (nt 2236 and 2248) in the G ORF to ACG to abrogate initiation of 283 
translation of the G protein, ΔGP/M (Fig. 3A). Furthermore, we deleted an intron II sequence 284 
within the L gene (nt 2410 to 3703) to create a linearized, intronless L gene, ΔGLLP/M (Fig. 285 
3A), with the idea that the deletion of the intron in L mRNA may not only lead to the efficient 286 
14 
 
production of L during the replication but also increase the capacity for insertion of foreign 287 
genes into the genome. 293T cells were transfected with the resultant plasmid, pFct-BDV 288 
ΔGP/M-GFP or pFct-BDV ΔGLLP/M-GFP, together with three helper plasmids (N, P and L) 289 
and the G expression plasmid, and then cocultured with Vero cells stably expressing BDV G, 290 
Vero-BG. At first, the rescue efficiency was compared between P/M-GFP, ΔGP/M-GFP and 291 
ΔGLLP/M-GFP viruses at 12 days after the cocultivation. As shown in Fig. 3B, the cells 292 
transfected with pFct-BDV ΔGLLP/M-GFP yielded a much higher level of recombinant virus 293 
than those with pFct-BDV ΔGP/M-GFP. Furthermore, although the numbers of transfected 294 
plasmids, as well as the cells used for the rescue of recombinant viruses, were different 295 
between ΔGLLP/M-GFP and P/M-GFP viruses, the rescue efficiency of L linearized construct 296 
was comparable to or more efficient than that of wt P/M-GFP vector, suggesting that 297 
linearized, intronless L gene enables efficient replication of rBDV.  298 
To examine the cell-free infectivity and stability of the ΔGLLP/M virus, the cell-free 299 
virus of rBDV ΔGLLP/M-GFP-infected Vero-BG cells were inoculated into either Vero-BG or 300 
parental Vero cells at an MOI of 0.01, and the growth kinetics of the viruses were monitored 301 
by IFA. Although the infection rate of ΔGLLP/M-GFP virus gradually increased in Vero-BG 302 
cells, the parental Vero cells did not support the propagation of the ΔGLLP/M-GFP virus (Fig. 303 
4A). Interestingly, however, the infection by rBDV ΔGLLP/M-GFP was stably maintained 304 
during the observation period of 24 days (Figs. 4A and 4B). The Vero cells persistently 305 
infected with ΔGLLP/M-GFP virus exhibited the nuclear dot structure specific for BDV 306 
replication. (Fig. 4B, insets). Western blotting confirmed the lack of G expression in rBDV 307 
ΔGLLP/M-GFP-infected Vero cells (Fig. 4C). The persistent infection of ΔGLLP/M-GFP 308 
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virus without propagation was also observed in human-derived oligodendroglioma OL cells 309 
(Fig. 4D). On the other hand, we investigated whether the lack of G expression and the 310 
deletion of an intron within L gene increase the capacity of ΔGLLP/M vector to insert foreign 311 
gene into the P/M region. As shown in Fig. 4E, the rBDV ΔGLLP/M harboring LacZ gene 312 
(3060 bp) was successfully rescued and established persistent infection in Vero-BG cells. All 313 
these observations demonstrated that G is essential for virus propagation but not for the 314 
maintenance of persistent infection of BDV and suggested that rBDV ΔGLLP/M is a 315 
non-propagating virus, which may provide safe, stable and high-capacity foreign gene 316 
delivery in vivo.  317 
 318 
The ΔGLLP/M vector shows that the carboxyl-terminal region in BDV G is essential for 319 
release of infectious particles.   In many virus vector systems, pseudotyping of the virus 320 
envelope protein may be an effective strategy to expand the host cell tropism. Furthermore, 321 
improvement of the efficacy of virus particle release from producer cells could be necessary 322 
to generate a high titer virus stock. Therefore, understanding the mechanisms of the release of 323 
BDV infectious particles, as well as the envelopment by BDV G, may be crucial for the 324 
development of further applications of the BDV P/M vector system. As a first step towards 325 
these goals, therefore, we tried to determine the region of BDV G essential for the release of 326 
infectious particles, using the ΔGLLP/M-GFP system. Previous studies clearly revealed that 327 
the CT region of the mononegavirus G glycoprotein may play a key role in assembly of 328 
infectious virus particles in concert with M (11, 12, 28). We thus generated a series of alanine 329 
substitution mutants in the CT region of BDV G (Fig. 5B) and transfected the expression 330 
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plasmids into a ΔGLLP/M-GFP virus persistently infected Vero cell line, Vero-ΔGLLGFP, 331 
which was obtained by limiting dilution of Vero cells infected with ΔGLLP/M-GFP virus. At 332 
48 h after transfection, the virus titers in the culture supernatants were evaluated in Vero cells. 333 
As shown in Fig. 5B, none of the mutants, except for the QE502/503A mutant, in which two 334 
residues at the end of the C terminus are substituted by alanine, could rescue the infectious 335 
viruses. This result indicated that at least the amino acids at positions 494 to 501 of BDV G 336 
are required for efficient release or infectious particle formation of BDV in the cells. 337 
We finally investigated whether the CT region of BDV G is required for the generation 338 
of pseudotyped rBDV harboring other virus envelope proteins. To this end, we at first 339 
transfected G expression plasmids of BDV, VSV, and RaV into the Vero-ΔGLLGFP cells, and 340 
at 48 h after transfection the virus titers in the culture supernatants were evaluated. As shown 341 
in Fig. 5D, although the cells transfected with BDV G plasmid yielded the rBDV in the 342 
supernatant as shown above, the infectivity was not detected in the supernatants of both VSV 343 
and RaV G-transfected cells. Interestingly, however, the chimeric VSV G, but not RaV G, of 344 
which the CT region is exchanged with that of BDV G (Fig. 5C), was shown to produce 345 
infectious particles in the culture supernatant of the transfected Vero-ΔGLLGFP cells (Fig. 346 
5E). These results suggested that the CT region of BDV G may enhance the efficiency of 347 
release or formation of pseudotyped rBDV using VSV G. All these data demonstrated that the 348 
ΔGLLP/M virus system may provide a useful tool not only for investigating the mechanisms 349 






In this study, we showed that foreign genes can be stably expressed from an intercistronic 354 
region of the BDV genome in both cultured and animal brain cells. Together with the 355 
previous report by Schneider et al (26), this suggests strongly that BDV may be a good vector 356 
platform for gene delivery to the CNS. In this study, it was very surprising that our system 357 
expressing several foreign genes from the P/M region enabled successful rescue of the rBDV, 358 
despite the fact that a vector with the same genome construction did not yield recombinant 359 
virus in a previous study (26). Although the factors accounting for this difference are not 360 
obvious, it is highly likely that only a single nucleotide difference exerts the adverse effects 361 
on the rescue of rBDV in the reverse genetics system. It will be of interest to compare the 362 
sequence differences between these vectors to understand the genomic feature necessary for 363 
BDV replication or propagation.  364 
Recently, Ackermann et al. reported that GFP expression from the rBDV 5’GFP 365 
construct is reduced markedly in mouse brains from two months postinfection, probably 366 
because of mutations in the termination/initiation signals upstream of inserted GFP gene (2). 367 
This observation suggests that expression of an additional gene from the 5’ end of BDV 368 
genome may have deleterious effects on virus replication, leading to attenuation of 369 
transcription of the inserted gene. The additional transcription initiation signal downstream of 370 
the L gene may affect the efficiency of the termination of transcription of L. Alternatively, the 371 
additional sequences may disrupt structures at the end of the BDV genome, such as the ITR 372 
and panhandle structures, important for the initiation of RNA replication and formation of the 373 
viral ribonucleoprotein (RNP) (24, 25, 27). Furthermore, very recently, Martin et al. clearly 374 
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showed that specific sequences in close proximity to the 3’ ends of the viral genome and 375 
antigenomic RNA are required for the elongation of the genomic RNA after the realignment 376 
of the 3’ termini (20). As this process could be essential for the maintenance of the 377 
BDV-specific genome-end structure during replication, it may be possible that the long extra 378 
sequences in the 5’ end of the genome disrupt the realignment of the 3’ terminus of 379 
antigenomic RNA, resulting in reduced virus replication. On the other hand, we demonstrated 380 
that the P/M-GFP virus exhibited no attenuation of the extra transcription unit, even in mouse 381 
brains during our observation periods of at least eight months. Sequencing analysis revealed 382 
that no attenuating mutations are introduced in the sequences of the inserted transcriptional 383 
unit. Furthermore, the expression levels of both P and M appeared not to differ between 384 
rBDV P/M and wt viruses. In addition, we could demonstrate that the P/M region must have a 385 
considerable capacity for insertion of various length foreign genes, at least below 3060 bp in 386 
ΔGLLP/M vector. All these observations indicated that P/M region may be a more flexible, 387 
stable and suitable site for insertion of an extra transcription cassette in the BDV genome, 388 
suggesting that the BDV P/M system provides an efficient platform as a BDV vector. 389 
The potential for pathogenesis is an important concern for many virus vectors and 390 
replication- and propagation-incompetent viral vectors have been created for safety reason. In 391 
this study, we tried to generate propagation-defective rBDV by deleting the G ORF, using the 392 
P/M vector system. The G ORF of BDV encodes an envelope glycoprotein, which overlaps 393 
with the upstream M ORF, and contains a long intron of a 1293 nt for expression of the 394 
downstream L gene (7, 31, 32). The G precursor protein, GP, plays a key role in BDV entry to 395 
susceptible cells and the GP1, the N-terminal subunit of GP, is known to be required for 396 
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receptor recognition and virus entry (14, 15, 16, 19, 22). Previous studies suggested that the 397 
expression and correct processing of BDV GP are necessary for BDV dissemination in 398 
primary cultures of neurons and that neutralizing antibodies against BDV GP completely 399 
inhibited virus spread (3). These observations suggested that the enveloped viral particles, not 400 
nonenveloped viral RNPs, are crucial for dissemination of BDV between cultured cells (3), as 401 
in the cases of other mononegaviruses, such as RaV (10). On the other hand, in an 402 
independent system, it was reported that cell-to-cell spread of BDV does not require the 403 
expression of the primary receptor, as well as the processing of BDV GP (6). These 404 
observations showed the complexity of the roles of G in BDV infectivity and propagation in 405 
neurons. In this study, we mutated the first two methionines and an intron (intron II) for the L 406 
gene in the G ORF of the P/M-GFP vector to generate rBDV-lacking the G envelope protein, 407 
ΔGLLP/M virus. The transiently enveloped-rBDV from G-expressing Vero cells showed 408 
cell-free infectivity and established persistent infection of Vero cells in the absence of G 409 
expression. Interestingly, the infection seemed to be maintained without spreading in the 410 
cultured cells, suggesting that BDV G is not required for the establishment of persistent 411 
infection in a single cell but rather for cell-to-cell spread. Our result revealed that persistent 412 
infection by the ΔGLLP/M-GFP virus can be maintained for at least more than 2 months 413 
without losing the expression of GFP (data not shown), demonstrating that the ΔGLLP/M 414 
system may provide a promising BDV vector for in vivo use with safe and persistent foreign 415 
gene expression in the infected cells.  416 
The ΔGLLP/M virus provided an intriguing finding that intron II of the L gene may 417 
negatively regulate the expression of L polymerase, because deletion of intron II markedly 418 
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enhances the efficiency of rescue of the rBDV when compared with the ΔGP/M virus. In 419 
addition, the L-linearized construct seemed to be more efficient than the wt P/M-GFP vector 420 
for rescue of rBDV, despite the trans-complementation of G in the rescue system. This result 421 
also demonstrated that the linearization of L gene does not have any adversary effect on the 422 
replication of rBDV. Previous studies revealed that the splice donor 2 (SD2; nt 2410) can 423 
produce two introns, introns II and III, in the BDV genome using alternative splicing 424 
machinery, which generate the mature L mRNA and predicted small ORFs, respectively (30). 425 
Because the SD2 sequence was mutated in the ΔGLLP/M vector, alternative splicing using 426 
intron III could be also defective in the recombinant viruses. Although control of the 427 
alternative splicing between introns II and III during BDV replication has not been elucidated 428 
yet, skipping over the splicing reactions of L transcripts might be likely to increase the 429 
polymerase activity, leading to high efficiency of rBDV rescue. Along with the LRD mutation, 430 
the regulation of L splicing may be a key to improve the recovery rate of rBDV in the reverse 431 
genetics system.  432 
Our analysis using rBDV ΔGLLP/M-GFP-infected cells also provided an excellent 433 
model for studying the release of infectious BDV and the virion formation in infected cells. 434 
Previous studies using other mononegaviruses revealed that M and G proteins may be critical 435 
for the assembly or budding of infectious virions in concert (11, 12, 28). In this study, we 436 
demonstrated that the CT region of BDV G may be essential for the release of infectious 437 
particles, using the rBDV ΔGLLP/M-GFP persistently infected cells. Our result showed that 438 
an 8-amino acid stretch, 494RRRRLGRW501, in the CT region may play a critical role in the 439 
production of infectious virions. Understanding the interaction between M and G of BDV 440 
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may provide valuable insights into, not only the improvement of the efficiency of infectious 441 
particle releases from BDV-infected cells, but also the generation of pseudotyped viruses 442 
using other virus envelope proteins. In fact, we could show that the chimeric VSV G protein 443 
harboring the CT region of BDV G facilitates the production of infectious particles in the 444 
supernatant of Vero-ΔGLLGFP cells (Fig. 5D). This result suggested that the function of the 445 
CT region of BDV G may be at least a necessary prerequisite, if not sufficient, to generate 446 
pseudotyped virions using the envelope proteins of other viruses. On the other hand, we could 447 
not obtain evidence that the chimeric RaV G having the BDV CT region produces infectious 448 
virions in the supernatant of the transfected cells. This may be due to the differences of the 449 
intracellular localization of the maturation and/or the budding of G proteins between BDV 450 
and RaV. Alternatively, in RaV infection the specific interaction of G with other viral 451 
components might be necessary for efficient virion assembly and release. The difference in 452 
efficiency of formation of pseudotyped virions by the source of the G protein may be a key to 453 
understand the life cycle of BDV, especially assembly and budding of virions.    454 
In this study, we could not demonstrate the detailed characteristics of the infectious 455 
virions released from the Vero-ΔGLLGFP cells by the trans-complementation assays, because 456 
the amount of infectious particles released into the supernatants were still low even in the 457 
supernatant of cells transfected with wt BDV G. Therefore, further studies using more detailed 458 
recombinant constructs between VSV, RaV and BDV G will be required to confirm the 459 
release mechanism and the efficient production of the pseudotyped virions in the ΔGLLP/M 460 
system, and such experiments are now underway in our laboratory. The pseudotyped BDV 461 
may not only extend the application of BDV vectors to many cell types and tissues other than 462 
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the CNS but also contribute to the development of low- or non-pathological rBDV lacking the 463 
immunogenicity of the envelope protein. 464 
We investigated the potential of BDV as a virus vector using a novel BDV vector 465 
system. Our results showed that the newly established BDV P/M vector may provide a good 466 
system not only for efficient and safe gene delivery in vivo but also for basic research 467 
regarding BDV replication and virion formation. Further improvements of the BDV P/M 468 
vector system, including the reduction of possible pathogenesis and expansion of the capacity 469 
for insertion of foreign genes, are necessary to establish a useful virus vector and are now in 470 
progress.  471 
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Figure legends 580 
 581 
Fig. 1. Efficient expression of GFP from an intercistronic P/M region of a BDV vector.  582 
(A) Schematic representation of a BDV vector construct harboring a GFP gene in an 583 
intercistronic region between the P and M genes. The genetic organization of BDV and the 584 
sequences surrounding the inserted transcription cassette are shown. The additional 585 
transcription start and termination signals (S3 and T2) and restriction enzyme sites (Bst BI 586 
and Pac I) are indicated. (B) Expression of GFP in rBDV P/M-GFP-infected Vero cells. The 587 
cell nuclei are stained by DPAI (blue). Bar, 10 μm. (C) Growth kinetics of wt and 588 
GFP-expressing rBDVs in Vero cells. The viral growth rate was monitored by IFA using 589 
anti-N mAb. Symbols; rBDV wt (closed circle), rBDV P/M-GFP (closed square), rBDV 590 
5’GFP (open triangle). (D) Comparison of the levels of GFP expression between rBDV 591 
P/M-GFP and rBDV 5’GFP in Vero cells. The rBDV-infected Vero cells were detected by 592 
anti-N mAb (red) and GFP fluorescence (green). Bar, 20 μm. (E) and (F) The expression 593 
levels of GFP protein and mRNA were determined by western (E) and northern (F) blot 594 
analyses, respectively. The antibodies (E) and riboprobes (F) used in the analyses are 595 
indicated to the left. (G and H) The BDV-P/M vector has a great capacity for insertion of 596 
various foreign genes of different lengths. (G) The Vero cells were infected with cell-free 597 
rBDV P/M-Luc at an MOI of 1.0. The luciferase activity was detected in the infected cells as 598 
early as 72 h after infection. Symbols; rBDV P/M-Luc (closed diamond), rBDV P/M-GFP 599 
(open square). RLU, relative luciferase unit. (H) Stable expression of DsRed in the Vero cells 600 




Fig. 2. rBDV P/M stably expresses GFP in rodent brains.  (A) The rat brains infected 603 
with rBDV P/M-GFP exhibited a brighter GFP signal than those with rBDV 5’GFP at 2 weeks 604 
postinoculation. The GFP expression was monitored by fluorescence stereomicroscopy. (B) 605 
The GFP fluorescence was compared between rats infected with rBDV P/M-GFP and 5’GFP 606 
in the cerebrum cortex and cerebellum at 2 months postinoculation. The cryosections of the 607 
brain samples were reacted with anti-N mAb. Merged images also are shown with nuclear 608 
DAPI staining (blue). Bar, 50 μm. (C) A representative stereomicroscopic image of the cross 609 
section of the brain of 2-month-old C57BL/6J mice neonatally infected with rBDV P/M-GFP. 610 
Immunohistochemical staining of the cryostat sections was examined by fluorescence 611 
microscopy following staining with an antibody specific for BDV N. Bar, 100 μm. (D) GFP 612 
signals in the brain of an 8-month-old mouse neonatally inoculated with rBDV P/M-GFP. The 613 
stereomicroscopic image of the sagittal section and the cryostat section of the brain are shown. 614 
Bar, 50 μm. 615 
 616 
Fig. 3. Construction and efficiency of rescue of the G-deficient BDV vectors.  (A) 617 
Schematic representations of the ΔGP/M-GFP and ΔGLLP/M-GFP vectors. Arrows indicate 618 
the sites of the first two methionine codons that were mutated in the G-deficient vectors. The 619 
region of intron II (nt 2410 to 3703) also is shown. (B) Comparison of rBDV rescue 620 
efficiency between ΔGP/M-GFP, ΔGLLP/M-GFP and P/M-GFP vectors. The numbers of 621 
GFP-positive focuses were counted by fluorescence microscopy at 12 days after cocultivation. 622 




Fig. 4. The G-deficient rBDV establishes persistent infection in cultured cells.  (A) 625 
Growth kinetics of ΔGLLP/M-GFP virus in Vero-BG and Vero cells. The cell-free virus was 626 
inoculated onto the cells at an MOI of 0.01. Infected cells were split every 3 days and GFP 627 
expression evaluated by fluorescent microscopy. The filled squares and open triangles 628 
indicate the infection rates of rBDVs in Vero-BG (left vertical axis) and Vero (right vertical 629 
axis) cells, respectively. (B) The fluorescence microscopic images of rBDV 630 
ΔGLLP/M-GFP-infected Vero-BG (left panel) and Vero (right panel) cells at 12 days 631 
postinfection. Cells were counterstained with DAPI. The cells were immunostained with 632 
anti-N mAb (red; insets). Merged images are shown. Bar, 50 μm (10 μm in insets). (C) 633 
Western blot analysis of ΔGLLP/M-GFP-infected Vero cells. The cloned Vero cells 634 
persistently infected with rBDV ΔGLLP/M-GFP were analyzed by western blotting using 635 
specific antibodies against BDV G (polyclonal) and N (monoclonal) and GFP (monoclonal). 636 
(D) The fluorescence microscopic images of rBDV ΔGLLP/M-GFP persistently infected OL 637 
cells. After the infection, the rBDV-infected cells were cloned by limiting dilution. The cells 638 
were immunostained with anti-N mAb (red). Cells were counterstained with DAPI. Merged 639 
images are shown. Bar, 20 μm. (E) Stable expression of LacZ in the Vero-BG cells infected 640 
with rBDV ΔGLLP/M-LacZ. Bar, 100 μm. 641 
 642 
Fig. 5. Identification of the carboxyl-terminal region in the BDV G cytoplasmic tail 643 
necessary for the release of infectious particles. (A) Schematic representation of BDV G. 644 
The amino acid number of BDV G is indicated. SP, signal peptide; TM, transmembrane 645 
31 
 
domain; CT, cytoplasmic tail. (B) Diagram of a series of alanine substitution mutants of CT 646 
region. The infectious titers in the supernatants of rBDV ΔGLLP/M-GFP-infected Vero cells 647 
transfected with each construct were monitored by focus-forming assay at 48 h after infection 648 
of the cells. The titers are shown to the right. N.D, not detected. (C) Schematic representation 649 
of VSV, RaV G, and chimeric G constructs. Bct, CT region of BDV G. (D and E) The 650 
infectious titers in the supernatants of the Vero-ΔGLLGFP cells transfected with G expression 651 
plasmids. The titers were monitored by focus-forming assay at 48 h after inoculation in Vero 652 
cells. ND, not detected. (E) VG-Bct and RV-Bct indicate chimeric VSV and RaV G constructs 653 
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